ホーム
投稿
マイページ
0
通知
ブックマーク
履歴
コメント
サブスクリプション
収益
設定
ヘルプ

利用規約
プライバシー
運営会社
お問い合せ
© 2025 Interhead, Inc.
baskadia

Baskadia

​
​

0 件のコメント

​

この投稿にコメントしよう!

この投稿にはまだコメントがありません。
ぜひあなたの声を聞かせてください。

Swollen

無料テキスト

COVID

AJMC Center for BiosimilarsCenter for Biosimilars Contributor: It’s Important to Prioritize HIV Care During the COVID-19 Pandemic August 13, 2022 Allison Fortier, Milena Murray, PharmD, MSc, BCIDP, AAHIVP Not all barriers to HIV-related care and services have been eliminated, and these gaps in care were exacerbated by treatment disruptions brought on by the COVIDC-19 pandemic. Approximately 37.9 million people living with HIV are at risk of infection with SARS-CoV-2, the virus that causes COVID-19.1 However, the COVID-19 pandemic created setbacks for individual and public health HIV treatment goals. These delays in care had many adverse effects. People were told to stay home, and many appointments and procedures were canceled.1 Further, those who may have received their diagnosis in the hospital could not follow up for care and receive treatment, and access to antiretroviral therapy (ART) was restricted during the pandemic, which led to decreased adherence. This, in

COVID
S
S